FDA Inspection 1303644 — Pyramid Laboratories, Inc.

Pyramid Laboratories, Inc. — FEI 1000160734

The FDA completed an inspection of Pyramid Laboratories, Inc. on February 13, 2026 in Costa Mesa, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 13, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Costa Mesa, CA (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
344521 CFR 211.65(a)Equipment construction - reactive surfaces